Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple therapy for H. pylori in IBS
NCT04512898Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Aug 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clarithromycin, metronidazole in irritable bowel syndrome (IBS), Helicobacter pylori infection, sponsored by Assiut University. Status: unknown.
02
Drugs
clarithromycinmetronidazole
03
Conditions
irritable bowel syndrome (IBS)Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04512898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04512898.